AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
[Recalled] Quantum Blue Adalimumab Assay — Premature failure | Health Canada 2021-12-08
The product on this page is subject to an official recall. We summarise the regulator's findings and the recommended action.
Recall details
| Product | Quantum Blue Adalimumab Assay |
|---|---|
| Category | General hospital and personal use |
| Issuing authority | HC |
| Reference | 63694 |
| Country of notice | Canada |
| Risk level | Type II |
| Hazard type | recall |
| Notice date | 08 December 2021 |
Why it was recalled
According to the HC notice, the identified hazard is: Premature failure
This Type II recall concerns General hospital and personal use products distributed in Canada and was recorded by HC. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Review the official notice to confirm whether your unit is affected.
Read the full official notice →
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
Shop Recalled Quantum Blue Adalimumab
As an Amazon Associate and eBay Partner, we may earn from qualifying purchases.
Related articles
- Understanding Imbiss Expiry and Shelf Life: A Complete Guide
- How to Factory Reset a Google Pixel 8: Step by Step
- The Healthiest Sandwich Options: A Guide to Nutritious and Delicious Meals
- Best Value Powdered Drinks: Affordable Nutrition and Taste in Every Scoop
- Unlocking the Benefits of Fair Trade Certified Products – A Consumer's Guide
- Best Surgelés for Vegans: A Guide to Flavorful, Ethical Frozen Treats
Explore by topic
Looking up a product? Use ProductGuru — free barcode & product database with 35M+ products. Search by EAN / UPC barcode.